Terazosin
NDC 71610-715, Terazosin Hydrochloride, capsule, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-715
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075317
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE1 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-715-60 | 71610071560 | 90 CAPSULE in 1 BOTTLE (71610-715-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2f2db826-182d-4dd1-af97-f874b57b1fb9
Use it
Look up 71610-715 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-715 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-715. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.